A Phase II Trial of Panobinostat, a Histone Deacetylase Inhibitor, in the Treatment of Patients with Refractory Metastatic Renal Cell Carcinoma - Concepedia

Concepedia

Publication | Closed Access

A Phase II Trial of Panobinostat, a Histone Deacetylase Inhibitor, in the Treatment of Patients with Refractory Metastatic Renal Cell Carcinoma

87

Citations

18

References

2011

Year

John D. Hainsworth, Jeffrey R. Infante, David R. Spigel, Edward Arrowsmith, Ralph V. Boccia, Howard A. Burris

Cancer Investigation

Abstract

Panobinostat had no activity in this group of patients with refractory renal carcinoma. Further development of panobinostat in renal carcinoma is not recommended.

References

	Year	Citations

Page 1